Ontology highlight
ABSTRACT:
SUBMITTER: Galetto R
PROVIDER: S-EPMC4362381 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
Galetto Román R Lebuhotel Celine C Poirot Laurent L Gouble Agnès A Toribio Maria L ML Smith Julianne J Scharenberg Andrew A
Molecular therapy. Methods & clinical development 20140611
Chimeric antigen receptor technology offers a highly effective means for increasing the anti-tumor effects of autologous adoptive T-cell immunotherapy, and could be made widely available if adapted to the use of allogeneic T-cells. Although gene-editing technology can be used to remove the alloreactive potential of third party T-cells through destruction of either the α or β T-cell receptor (TCR) subunit genes, this approach results in the associated loss of surface expression of the CD3 complex ...[more]